Reuters logo
BRIEF-Arog Pharma Receives FDA Fast Track Designation for Crenolanib
December 1, 2017 / 12:14 PM / 12 days ago

BRIEF-Arog Pharma Receives FDA Fast Track Designation for Crenolanib

Dec 1 (Reuters) - Arog Pharmaceuticals Inc

* AROG PHARMACEUTICALS RECEIVES FDA FAST TRACK DESIGNATION FOR CRENOLANIB IN RELAPSED OR REFRACTORY FLT3-POSITIVE AML Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below